BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Ph II Neurology 2018 Allogene Therapeutics Inc. (NASDAQ:ALLO) San Francisco, Calif. $300.0 TPG Capital , Bellco Capital LLC...
Items per page:
1 - 1 of 1
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Ph II Neurology 2018 Allogene Therapeutics Inc. (NASDAQ:ALLO) San Francisco, Calif. $300.0 TPG Capital , Bellco Capital LLC...
Items per page:
1 - 1 of 1